APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42
- PMID: 21159973
- PMCID: PMC3023180
- DOI: 10.1523/JNEUROSCI.3987-10.2010
APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42
Abstract
Identifying high-risk populations is an important component of disease prevention strategies. One approach for identifying at-risk populations for Alzheimer's disease (AD) is examining neuroimaging parameters that differ between patients, including functional connections known to be disrupted within the default-mode network. We have previously shown these same disruptions in cognitively normal elderly who have amyloid-β (Aβ) plaques [detected using Pittsburgh Compound B (PIB) PET imaging], suggesting neuronal toxicity of plaques. Here we sought to determine if pathological effects of apolipoprotein E ε4 (APOE4) genotype could be seen independent of Aβ plaque toxicity by examining resting state fMRI functional connectivity (fcMRI) in participants without preclinical fibrillar amyloid deposition (PIB-). Cognitively normal participants enrolled in longitudinal studies (n = 100, mean age = 62) who were PIB- were categorized into those with and without an APOE4 allele and studied using fcMRI. APOE4 allele carriers (E4+) differed significantly from E4- in functional connectivity of the precuneus to several regions previously defined as having abnormal connectivity in a group of AD participants. These effects were observed before any manifestations of cognitive changes and in the absence of brain fibrillar Aβ plaque deposition, suggesting that early manifestations of a genetic effect can be detected using fcMRI and that these changes may antedate the pathological effects of fibrillar amyloid plaque toxicity.
Figures
Similar articles
-
Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly.Biol Psychiatry. 2010 Mar 15;67(6):584-7. doi: 10.1016/j.biopsych.2009.08.024. Epub 2009 Oct 14. Biol Psychiatry. 2010. PMID: 19833321 Free PMC article.
-
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Ann Neurol. 2010 Jan;67(1):122-31. doi: 10.1002/ana.21843. Ann Neurol. 2010. PMID: 20186853 Free PMC article.
-
CSF proteins and resting-state functional connectivity in Parkinson disease.Neurology. 2015 Jun 16;84(24):2413-21. doi: 10.1212/WNL.0000000000001681. Epub 2015 May 15. Neurology. 2015. PMID: 25979701 Free PMC article.
-
Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.Rev Neurol (Paris). 2013 Oct;169(10):729-36. doi: 10.1016/j.neurol.2013.07.025. Epub 2013 Sep 6. Rev Neurol (Paris). 2013. PMID: 24016463 Review.
-
Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.Neuropsychol Rev. 2014 Sep;24(3):290-9. doi: 10.1007/s11065-014-9263-8. Epub 2014 Aug 22. Neuropsychol Rev. 2014. PMID: 25146994 Review.
Cited by
-
Interaction of age and APOE genotype on cerebral blood flow at rest.J Alzheimers Dis. 2013;34(4):921-35. doi: 10.3233/JAD-121897. J Alzheimers Dis. 2013. PMID: 23302659 Free PMC article.
-
Resting state functional MRI in Alzheimer's Disease.Alzheimers Res Ther. 2012 Jan 10;4(1):2. doi: 10.1186/alzrt100. Alzheimers Res Ther. 2012. PMID: 22236691 Free PMC article.
-
Differences in functional brain connectivity alterations associated with cerebral amyloid deposition in amnestic mild cognitive impairment.Front Aging Neurosci. 2015 Feb 19;7:15. doi: 10.3389/fnagi.2015.00015. eCollection 2015. Front Aging Neurosci. 2015. PMID: 25745400 Free PMC article.
-
Alzheimer disease family history impacts resting state functional connectivity.Ann Neurol. 2012 Oct;72(4):571-7. doi: 10.1002/ana.23643. Ann Neurol. 2012. PMID: 23109152 Free PMC article.
-
Insula and Inferior Frontal Gyrus' Activities Protect Memory Performance Against Alzheimer's Disease Pathology in Old Age.J Alzheimers Dis. 2017;55(2):669-678. doi: 10.3233/JAD-160715. J Alzheimers Dis. 2017. PMID: 27716674 Free PMC article.
References
-
- Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368:387–403. - PubMed
-
- Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709–7717. - PMC - PubMed
-
- Cairns NJ, Ikonomovic MD, Benzinger T, Storandt M, Fagan AM, Shah A, Reinwald LT, Carter D, Felton A, Holtzman DM, Mintun MA, Klunk WE, Morris JC. Absence of Pittsburgh Compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease. Arch Neurol. 2009;66:1557–1562. - PMC - PubMed
-
- Carmichael ST, Price JL. Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys. J Comp Neurol. 1996;371:179–207. - PubMed
-
- Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM. P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest. 2005;115:3285–3290. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 NS006833/NS/NINDS NIH HHS/United States
- P01 AG026276/AG/NIA NIH HHS/United States
- P01AG03991/AG/NIA NIH HHS/United States
- K24 MH079510-06/MH/NIMH NIH HHS/United States
- P30 NS048056/NS/NINDS NIH HHS/United States
- P50AG05681/AG/NIA NIH HHS/United States
- P01AG026275/AG/NIA NIH HHS/United States
- K24 MH079510/MH/NIMH NIH HHS/United States
- K24MHO79510/PHS HHS/United States
- P01 AG003991/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30NS048056/NS/NINDS NIH HHS/United States
- P30NS06833/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources